home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Analysis of inhaled products

  April 09, 2009  
Royal Pharmaceutical Society of Great Britain, London
Thursday 15 October 2009

10.00 Introduction - Dr Ray Munden, Chairman, Joint Pharmaceutical Analysis Group 

10.05 Regulatory overview: key analytical issues in global product approval - Dr Prasad Peri, FDA

10.45 Formulators perspective: key analytical issues in expediting product development - Dr Philippe Rogueda, Novartis

11.20 Relationship between in-vitro and in-vivo data - Gary Pitchairn, Pfizer

11.55 Current issues in cascade impaction - Frank Chambers, AZ

12.30 Lunch

13.45 Recent experiences with automation of inhaled product testing - Dave Russell-Graham, Pfizer, and Andy Rice, GSK

14.20 Evaluating the robustness of drug delivery from nasal spray and   nebuliser devices using laser diffraction particle sizing
Dr Paul Kippax, Malvern Instruments

14.55 Powder rheology as a tool for predicting formulation performance - Professor Rob Price. University of Bath

15.30 Use of NMR in pMDI development - Dr Dave Martin, AZ

16.05 Closing remarks

16.15 Close

Organized by: Royal Pharmaceutical Society of Great Britain
Invited Speakers: See programme
Deadline for Abstracts: n/a
Registration: 09.30  Registration and coffee
E-mail: events@rpsgb.org
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.